Azithromycin or montelukast as inhaled corticosteroid–sparing agents in moderate-to-severe childhood asthma study
Robert C. Strunk(Washington University in St. Louis), Gary L. Larsen(National Jewish Health), Ian M. Paul(Pennsylvania State University), Christine A. Sorkness(University of Wisconsin–Madison), Stanley J. Szefler(Children's Hospital Colorado), Robert S. Zeiger(Kaiser Permanente), Theresa W. Guilbert(University of Arizona), Fernando D. Martínez(University of Arizona), Leonard B. Bacharier(Washington University in St. Louis), David T. Mauger(Pennsylvania State University), Wayne J. Morgan(University of Arizona), Lynn M. Taussig(Northwestern University), Brenda R. Phillips(Pennsylvania State University), Ronina Covar(National Jewish Health), Marzena Krawiec(University of Wisconsin–Madison), Robert F. Lemanske(University of Wisconsin–Madison), Vernon M. Chinchilli(Pennsylvania State University)
Cited by 137
Related Papers
Asthma and Wheezing in the First Six Years of Life
|New England Journal of Medicine|1995|3.8k
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
|The Lancet|1999|1.6k
Lebrikizumab Treatment in Adults with Asthma
|New England Journal of Medicine|2011|1.5k